GLPwatch
Trials (2036)
Page 12 of 34.
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
- A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
- Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
- The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)
- Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
- A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
- Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
- Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
- Exenatide for Myocardial Protection During Reperfusion Study
- Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)
- Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
- Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
- A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment
- Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)
- A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Trial of EXenatide in Acute Ischaemic Stroke
- A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
- A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
- Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
- Semaglutide and Vascular Regeneration
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
- Incretin Effect on the Immunological Phenotype
- Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
- RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
- The Long COVID Treatment Trial
- Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
- Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
- Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
- A Study in Participants With Type 2 Diabetes Mellitus
- A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.
- Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
- Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
- Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
- A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
- Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity
- A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose
- Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity
- Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
- An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
- A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- Semaglutide and Cognition in Healthy Volunteers
- Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
- Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
- Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.
- Semaglutide in CFRD
- Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity
- A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2
- Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- GLP-1 RA for Stage 1 Type 1 Diabetes
- A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
- A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
- Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
- Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects